logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + proprietary hiring database
✓Executive contact details included
INDUSTRY FIRST

Heron Therapeutics Appoints Brett Fleshman As Chief Business Officer

Sep 05, 2024•12 months ago

Position

Chief Executive Officer

Company

Heron Therapeutics

Craig Collard
San Diego

Description

Heron Therapeutics, Inc. announced the appointment of Brett Fleshman as Chief Business Officer. Mr

Company Information

Company

Heron Therapeutics

Location

San Diego, California, United States

About

At Heron, we aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies to deliver medicines that matter.

Company News

(9 articles)
Tue, 06 May 2025 07:00:00 GMT

Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates - PR Newswire

Mon, 23 Dec 2024 08:00:00 GMT

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina - PR Newswire

Fri, 08 Aug 2025 07:00:00 GMT

Heron Therapeutics Reschedules Second Quarter 2025 Earnings Release and Conference Call to Friday, August 8, 2025 - Finansavisen

Tue, 03 Sep 2024 07:00:00 GMT

Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer - PR Newswire

Mon, 28 Apr 2025 07:00:00 GMT

Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer - PR Newswire

Tue, 12 Nov 2024 08:00:00 GMT

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - PR Newswire

Tue, 06 May 2025 07:00:00 GMT

Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations - PR Newswire

Tue, 06 Aug 2024 07:00:00 GMT

Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance - PR Newswire

Mon, 04 Nov 2024 08:00:00 GMT

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - PR Newswire

FundzWatch™ Score

64
Medium Activity

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months